clinical trial · NCT05364606
Patient Specific Talus Spacer Post Approval Study
Paragon 28·—·recruiting·n = 50
Avascular Necrosis of the TalusPatient Specific Talus Spacer
brief summary
Humanitarian Device Exemption Approved Patient Specific Talus Spacer Post Approval Study.
started
Jul 8, 2022
primary completion
Aug 30, 2029
completion
Nov 30, 2029
last updated
Nov 7, 2024
detailed description
This is a Humanitarian Device Exemption (HDE) approved device called the Patient Specific Talus Spacer. This is a post approval study to determine the safety and probable benefit of the Patient Specific Talus Spacer in commercial use. The Patient Specific Talus Spacer is a solid polished replica of the patient's bone to allow the patient to regain motion and reduce pain.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol